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We present a 20-year-old female patient from Indonesia with intellectual disability (ID), proportionate short stature, motor
delay, feeding problems, microcephaly, facial dysmorphism, and precocious puberty who was previously screened normal for
conventional karyotyping, fragile X testing, and subtelomeric MLPA analysis. Subsequent genome wide array analysis was
performed on DNA from blood and revealed a 1.1Mb deletion in 14q32.2q32.31 (chr14:100,388,343-101,506,214; hg19). Subsequent
carrier testing in the parents by array showed that the deletion had occurred de novo in the patient and that her paternal 14q32
allele was deleted. The deleted region encompasses the DLK1/GTL2 imprinted gene cluster which is consistent with the maternal
UPD(14)-like phenotype of the patient. This rare, recurrent microdeletion was recently shown not to be mediated by low copy
repeats, but by expanded TGG repeats, flanking the 14q32.2q32.21 deletion boundaries, a novel mechanism of recurrent genomic
rearrangement. This is another example how the application of high resolution genome wide testing provides an accurate genetic
diagnosis, thereby improving the care for patients and optimizing the counselling for family.
1. Introduction
Theapplication of high resolution genomewide array analysis
provides an accurate genetic diagnosis in many patients
with ID and/or congenital anomalies caused by genomic
imbalances. The use of this technology has led to the dis-
covery of several novel microdeletion and microduplication
syndromes. Although several patients have been reported
with a terminal 14q32 deletion, patients with an in terstitial
microdeletion in the 14q32 region seem to be rare. To our
knowledge, only two patients with an interstitial 1.1Mb
deletion in q32.2q32.31 have previously been reported [1, 2].
Human chromosome 14q32.2 is the critical region for uni-
parental disomy of chromosome 14 (UPD(14)) phenotypes
because it carries a cluster of imprinted genes, including the
paternally expressed genes (PEGs) such as DLK1&RTL1 and
the maternally expressed genes (MEGs) such as GTL2 (also
known asMEG3),RTL1as (RTL1 antisense), andMEG8.Dele-
tion of the paternal allele in this region causes a UPD(14)mat-
like phenotype [3]. Uniparental disomy (UPD) occurs when
the two copies of a chromosome pair are inherited from
only one parent [4]. Maternal UPD of chromosome 14
(UPD(14)mat) is characterized by pre- and postnatal growth
retardation, hypotonia, feeding problems, motor delay, short
stature, early onset of puberty, and minor dysmorphic fea-
tures of the face, hands, and feet [5]. Seven out of eleven
UPD(14)mat-like cases without UPD have been reported to
carry a deletion in the 14q32.2 region [2, 3, 6–9].
Here we report an additional female patient with a
1.1Mb deletion of chromosome 14 in the q32.2q32.31 region
identified by high resolution genome wide SNP array analy-
sis.
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Figure 1: Photograph of Indonesian patient with a 14q32.2 microdeletion. Our 20-year-old patient showed extremely short and thin stature,
flat face, flat philtrum, thin lips, tapering fingers, clinodactyly of the fifth finger on the right hand, and clubbing feet toes.
2. Case Report
A 20-year-old female Indonesian Javanese patient presented
with extremely thin and short stature, microcephaly, motor
delay, hypotonia, mild intellectual disability, flat face, flat
philtrum, thin lips, tapering fingers, clinodactyly of her fifth
finger on the right hand, clubbing feet toes, feeding problems,
and precocious puberty (Figure 1). She was born at 32 weeks
of pregnancy with a low birth weight of 1,800 g (p5–10) as
the second child of healthy, unrelated parents. At the time
of her birth, her mother was 24 years of age, and her father
was 33 years of age.There was no family history of intellectual
disability. Postnatally, she was found to have feeding problem,
motor delay, hypotonia, and precocious puberty. She was
able to walk at three years of age and able to speak at two
years of age. When she was examined at 20 years of age,
her body height was 130 cm (𝑃 < 3), her weight was 18 kg
(𝑃 < 3), and her arm spanwas 125 cm.Her ratio height to arm
span was 0.96 cm, thus showing proportionate short stature.
She has microcephaly with an occipital frontal circumference
(OFC) of 50 cm (𝑃 < 3). Previously, genetic tests were done,
including conventional karyotyping, subtelomeric MLPA,
and fragile X testing, all of which showed normal results [10].
Informed consent for publishing results and photos has been
obtained from the patient’s parents.
We performed genome wide array analysis on DNA
from blood using the Affymetrix CytoScan HD Array plat-
form (Affymetrix, Inc., Santa Clara, CA, USA) following
the manufacturer’s protocols, which showed a 1.1Mb dele-
tion in 14q32.2q32.31 (chr14:100,388,343-101,506,214; hg19) as
depicted in Figure 2(a). Subsequent carrier testing with the
same array platform in the parents revealed that the deletion
had occurred de novo in the patient (Figure 2(b)) and that
her paternal 14q32 allele was deleted. The possible presence
of either a balanced chromosomal rearrangement and/or
mosaic imbalance in the father was subsequently studied
by fluorescence in situ hybridization (FISH) analysis using
a FISH probe (RP11-123M6; BlueGnome Ltd., Cambridge,
UK) specific for the 14q32.2q32.31 region. These FISH results
showed that the father did not carry a balanced rearrange-
ment and/or mosaic imbalance (Figure 3).
3. Discussion
Here we report an additional patient with a rare, recurrent,
de novo 14q32.2q32.31 microdeletion of 1.1Mb. Two other
(female) patients have been reported in the literature with a
similar 1.1Mb microdeletion in 14q32.2q32.31 [1, 2]. Compa-
rable to our patient, it concerned a de novo loss of paternal
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Figure 2: (a) Array plots of chromosome 14, visualized using the Affymetrix Chromosome Analysis Suite (ChAS) Software. A 1.1Mb loss
in 14q32.2q32.31 was detected in Patient 1 (arr[hg19] 14q32.2q32.31(100,388,343-101,506,214)x1 dn) as indicated by the red rectangle. (b) Trio
analysis confirms that the deletion has occurred de novo in the patient.
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Figure 3: FISH study in the patient and her father. In each of them, 30metaphases from cultured peripheral blood lymphocytes were analysed.
(a) Patientmetaphase showing one normal chromosome 14 [RP11-123M6 (green)/14 qter 9 (red)] and the del(14)(q32.2q32.31) with only 14 qter
signal (red). (b) Metaphase from the father with a normal FISH pattern, indicating two normal chromosomes 14.
14q32 allele in both patients, who exhibited clinical features
compatible with UPD-(14)-mat (genomic coordinates and
clinical features in hg 19 are shown in Table 1).
This deleted region comprises a snoRNA, part of a
microRNA cluster, and 15 protein-coding genes, containing
a cluster of imprinted genes including paternally expressed
genes DLK1&RTL1 and maternally expressed genes GTL2
(also known as MEG3), RTL1as, and MEG8. The deleted
paternal 14q32 allele causes a maternal UPD(14)-like phe-
notype [3]. The other 10 genes are not imprinted (EVL,
DEGS2, YY1, SLC25A29, c14orf68, WARS, WDR25, BEGAIN,
c14orf70, and the 3’end of EML1).
Other than pre- and postnatal growth retardation, preco-
cious puberty, and feeding problems, which are compatible
with UPD(14)mat phenotypes, the patient reported here also
manifested intellectual disability (ID) which is not or rarely
observed in patients with UPD(14)mat. Considering that the
1.1Mb 14q32 deletion also encompasses many nonimprinted
genes, it is likely that the ID in this patient is caused by
haploinsufficiency of one or more dosage-sensitive genes.
For example, the BEGAIN (brain-enriched guanylate kinase-
associated protein) gene represents a good candidate based
on its localization in the neuronal synapse [11]. The recently
reported YY1 gene is considered to be an ID disease gene
based on the exome sequencing in a patient with unex-
plained ID in whom a missense mutation c.1138G>T with
protein level change p.Asp380Tyr was found [12]. This gene
implicates chromatin remodelling as its main function by
encoding the ubiquitously expressed transcription factor
yin-yang 1 and directing histone acetylases and histone
acetyltransferases. Experiments with Yy1 knockdown mice
resulted in growth retardation, neurulation defects, and brain
abnormalities [13].
Most recurrent genomic rearrangements are due to non-
allelic homologous recombination (NAHR) between mis-
aligned low copy repeats resulting in a microdeletion or
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Table 1: Genomic coordinates and clinical features of all cases.
Buiting et al., 2008 [2] Be´na et al., 2010 [1] Present case
Deletion positions (Mb) in
chromosome 14 (hg 19) 100.396–101.502 100.400–101.500 100.388–101.506
Sex Female Female Female
Age (years) 14
1
4
4 20
Pre- and postnatal growth
retardation + + +
Hypotonia + + +
Feeding problems + + +
Precocious puberty + ? +
Intellectual disability + + +
Dysmorphism −
High forehead, small chin,
posteriorly rotated ears, and flat
feet
Flat face, flat philtrum, thin lips,
tapering fingers, clinodactyly of the
fifth finger on the right hand, and
clubbing feet toes
Others − Hypermetropia −
+: present; −: not present; ?: undetermined yet.
a microduplication [14]. However, a recent paper by Be´na
et al. [1] reported the observations regarding the mecha-
nism underlying the recurrent 14q32.2 deletion described
here. They found that large (TGG)n tandem repeat tracts
of about 500 bp are at both boundaries of the dele-
tion (chr14:100,394,091-100,394,594 and chr14:101,504,592-
101,505,016; hg19). The TGG repeats are the longest type
of triplets motif and highly capable of forming G4 DNA.
Some theories might explain how these triplet repeats
can cause genomic rearrangement. First, expanded triplet
repeats would provide an aggravated substrate for genomic
rearrangement through the NAHR mechanism [15, 16].
Second, expanded triplet repeats have the tendency to
form intramolecular secondary structures termed guanine
quadruplexes or G4 DNA which could promote double
strand chromosome breaks [17]. Therefore, it is suggested
that this recurrent 14q32.2 microdeletion is mediated by
expanded TGG repeats, a novel mechanism of recurrent
genomic rearrangement that is shown not to be mediated by
low copy repeats.
In conclusion, we were able to detect a rarely identified
14q32.2 microdeletion by using high resolution genome wide
array analysis in a patient whose genotype and phenotype
are in agreement with those of two previously reported
patients in the literature. This case report demonstrates the
value of applying high resolution genome wide testing for
accurate genetic diagnosis that can help to improve the care
for patients and to optimize the counselling for family.
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